Overview


Diabetic lancing machines are used to take blood samples to test for glucose. They are commonly used in diagnostic centers, hospitals, clinics, clinics, and at home. The lancet's simple design makes it easy for patients to self-diagnose and monitor their diabetes. There are many lancet types available: disposable, flake, and stainless steel lancets; blood lancet pens; pull top, twist, universal, suction, pressure activated, push button, side button, fixed depth, safety, and pressure lancet. Some of the special features include a sharp blade or needle, minimal stick exposure, a safety device to protect against unwanted sticks, disposable, self-testing, single-use device, and a disposable, self–testing device. There are three main types of lancets: safety lancets and standard lancets. While the standard lancets tend to be the most affordable and feature a simple design they are much more popular than the safety models. There are two kinds of safety lancets, manual lancets, and automatic lancets. To deploy a spring-activated needle, manual devices must be removed from the shield and stabbed into the patient. Automated lancets can be activated by either pressure or contact with the sample. It is efficient in drawing a sufficient blood sample. It can be used to draw blood samples with less pain. To obtain glucose levels testing samples, lancing equipment, and devices are used. Safety lancets, and standard lancets, are the most important products of lancing apparatus and equipment. Safety lancets, which are single-use sterilized devices for sampling blood from capillaries, are disposable and sterile. You can choose from a variety of penetration depths including 0.8mm-1mm to 1.1mm-1.5mm, 1.6mm-2.25mm, and more. Hospitals and clinics, hospitals, home care, and home diagnostics, as well as medical institutions and diagnostic centers, research, and academic labs, are the end-users.
Lancing devices and equipment are in high demand due to the rising incidence of diabetes. More people rely on them to test their glucose levels. Diabetic patients use lancing to take blood samples and test their glucose levels. The market for lancing devices and other equipment is being restrained by recalls of defective devices. The manufacturer or regulator will call for a product recall if safety issues or defects are identified that could pose a danger to the consumer. Devices and equipment that penetrate the skin come in direct contact with the blood. Any defect in a product could cause a blood infection, which can pose a danger to the patient's safety and life. Roche Diagnostics Operations Inc. recalled the ACCUCHECK FastClix Lancing Device because the needle that was used to make a finger stick was not fully retracting into the drum. These recalls discourage the use of the product and impact the growth in the market. In order to reduce pain from poking, manufacturers of lancing devices are using more custom vacuum technology. The vacuum technology is used in lancing devices to create a small puncture in the skin that doesn't hit the deeper pain nerves. Genteel Lancing is an example of a vacuum blood-drawing lancing device. This draws blood from the veins and can be used anywhere on the body, including fingers.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Diabetic Lancing Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Diabetic Lancing Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

• Abbott Laboratories
• Allison Medical Inc
• Artsana Group
• Arkray Inc
• Bayer AG
• becton Dickinson and Company
• B.Braun Melsungen
• Eli Lilly and Company
• F.Hoffmann-La Roche AG
• Greiner Bio-One International GmbH
(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type
• Standard Lancets
• Safety Lancets
• Flake Lancets
• Fixed Depth Lancet
• Others
By Gauge Size
• 17/18g
• 21g
• 23g
• 25g
• 28g
• 30g
• Others
By Penetration Depth
• 8mm to 1.0 mm
• 1.1 mm to 1.5 mm
• 1.6 mm to 2.0 mm
• 2.1 mm to 2.5 mm
• 2.5 mm to 3.0 mm
• Others
By End User
• Research and Development
• Hospitals
• Clinics
• Home care and Home Diagnostics
• Diagnostic Centers and Medical Institutions
By Region
North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

• To provide with an exhaustive analysis on the Diabetic Lancing Devices Market By Product Type, By Gauge Size, By Penetration Depth, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Diabetic Lancing Devices Market Variables, Trends
    • Scope
        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances
  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Diabetic Lancing Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Diabetic Lancing Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Diabetic Lancing Devices Market, By Product Type Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Standard Lancets
        2. Safety Lancets
        3. Flake Lancets
        4. Fixed Depth Lancet
        5. Others
  • 8.   Diabetic Lancing Devices Market, By Gauge Size Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. 17/18g
        2. 21g
        3. 23g
        4. 25g
        5. 28g
        6. 30g
        7. Others
  • 9.   Diabetic Lancing Devices Market, By Penetration Depth Historical Analysis and Forecast 2024-2032 (USD Million)
    •     1. 8 mm to 1.0 . mm
          2. 1.1 mm to 1.5 . mm
          3. 1.6 mm to 2.0 . mm
          4. 2.1 mm to 2.5 . mm
          5. 2.5 mm to 3.0 . mm
          6. Others

  • 10.   Diabetic Lancing Devices Market, By End User Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Research and Development
        2. Hospitals
        3. Clinics
        4. Home care and Home Diagnostics
        5. Diagnostic Centers and Medical Institutions
  • 11.   North America Diabetic Lancing Devices Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032
  • 12.   Latin America Diabetic Lancing Devices Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032
  • 13.   Europe Diabetic Lancing Devices Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Germany
          2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032
  • 14.   Asia Pacific Diabetic Lancing Devices Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032
  • 15.   Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032
  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Abbott Laboratories
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Allison Medical Inc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Artsana Group
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Arkray Inc
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Bayer AG
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. becton Dickinson and Company
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. B.Braun Melsungen
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Eli Lilly and Company
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. F.Hoffmann-La Roche AG
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Greiner Bio-One International GmbH
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients